TRIM30α negatively regulates TLR-mediated NF-κB activation by targeting TAB2 and TAB3 for degradation

被引:216
|
作者
Shi, Mude [2 ]
Deng, Weiwen [2 ]
Bi, Enguang [2 ]
Mao, Kairui [2 ]
Ji, Yongyong [2 ]
Lin, Guomei [2 ]
Wu, Xiaodong [2 ]
Tao, Zhiyun [2 ]
Li, Zhenhu [2 ]
Cai, Xinfen [2 ]
Sun, Shuhui [3 ]
Xiang, Charlie [1 ]
Sun, Bing [2 ,4 ,5 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diagnosis & Treatment Infect Dis, Hangzhou 31003, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China
[3] Fudan Univ, Shanghai Med Coll, Shanghai 200032, Peoples R China
[4] Chinese Acad Sci, Inst Pasteur, Shanghai 200025, Peoples R China
[5] Shanghai Univ E Inst, Div Immunol, Shanghai 200025, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1038/ni1577
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Toll-like receptor (TLR) signaling is pivotal to innate and adaptive immune responses and must be tightly controlled. The mechanisms of TLR signaling have been the focus of extensive studies. Here we report that the tripartite-motif protein TRIM30 alpha, a RING protein, was induced by TLR agonists and interacted with the TAB2-TAB3-TAK1 adaptor-kinase complex involved in the activation of transcription factor NF-kappa B. TRIM30 alpha promoted the degradation of TAB2 and TAB3 and inhibited NF-kappa B activation induced by TLR signaling. In vivo studies showed that transfected or transgenic mice overexpressing TRIM30a were more resistant to endotoxic shock. Consistent with that, in vivo 'knockdown' of TRIM30a mRNA by small interfering RNA impaired lipopolysaccharide-induced tolerance. Finally, expression of TRIM30a depended on NF-kappa B activation. Our results collectively indicate that TRIM30a negatively regulates TLR-mediated NF-kappa B activation by targeting degradation of TAB2 and TAB3 by a 'feedback' mechanism.
引用
收藏
页码:369 / 377
页数:9
相关论文
共 50 条
  • [1] TRIM30α negatively regulates TLR-mediated NF-κB activation by targeting TAB2 and TAB3 for degradation
    Mude Shi
    Weiwen Deng
    Enguang Bi
    Kairui Mao
    Yongyong Ji
    Guomei Lin
    Xiaodong Wu
    Zhiyun Tao
    Zhenhu Li
    Xinfen Cai
    Shuhui Sun
    Charlie Xiang
    Bing Sun
    Nature Immunology, 2008, 9 : 369 - 377
  • [2] USP15 potentiates NF-κB activation by differentially stabilizing TAB2 and TAB3
    Zhou, Qiaoqiao
    Cheng, Cheng
    Wei, Yujuan
    Yang, Jing
    Zhou, Wanzhu
    Song, Qiuyi
    Ke, Mengxiang
    Yan, Wanyao
    Zheng, Ling
    Zhang, Yu
    Huang, Kun
    FEBS JOURNAL, 2020, 287 (15) : 3165 - 3183
  • [3] TAB2 and TAB3 activate the NF-κB pathway through binding to polyubiquitin chains
    Kanayama, A
    Seth, RB
    Sun, LJ
    Ea, CK
    Hong, M
    Shaito, A
    Chiu, YH
    Deng, L
    Chen, ZJ
    MOLECULAR CELL, 2004, 15 (04) : 535 - 548
  • [4] TRIM38 regulates NF-κB activation through TAB2 degradation in osteoclast and osteoblast differentiation
    Kim, Kabsun
    Kim, Jung Ha
    Kim, Inyoung
    Seong, Semun
    Kim, Nacksung
    BONE, 2018, 113 : 17 - 28
  • [5] Stabilization of the TAK1 adaptor proteins TAB2 and TAB3 is critical for optimal NF-κB activation
    Braun, Harald
    Staal, Jens
    FEBS JOURNAL, 2020, 287 (15) : 3161 - 3164
  • [6] RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-κB activation by targeting TAB2/3 for degradation
    Tian, Yang
    Zhang, Yan
    Zhong, Bo
    Wang, Yan-Yi
    Diao, Fei-Ci
    Wang, Rui-Peng
    Zhang, Min
    Chen, Dan-Ying
    Zhai, Zhong-He
    Shu, Hong-Bing
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (23) : 16776 - 16782
  • [7] TRIM22 Inhibits the TRAF6-stimulated NF-κB Pathway by Targeting TAB2 for Degradation
    Hui Qiu
    Fang Huang
    Han Xiao
    Binlian Sun
    Rongge Yang
    Virologica Sinica, 2013, 28 (04) : 209 - 215
  • [8] TRIM22 Inhibits the TRAF6-stimulated NF-κB Pathway by Targeting TAB2 for Degradation
    Hui Qiu
    Fang Huang
    Han Xiao
    Binlian Sun
    Rongge Yang
    Virologica Sinica, 2013, (04) : 209 - 215
  • [9] The SUMOylation of TAB2 mediated by TRIM60 inhibits MAPK/NF-κB activation and the innate immune response
    Gu, Zhiwen
    Chen, Xueying
    Yang, Wenyong
    Qi, Yu
    Yu, Hui
    Wang, Xiaomeng
    Gong, Yanqiu
    Chen, Qianqian
    Zhong, Bo
    Dai, Lunzhi
    Qi, Shiqian
    Zhang, Zhiqiang
    Zhang, Huiyuan
    Hu, Hongbo
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (08) : 1981 - 1994
  • [10] The SUMOylation of TAB2 mediated by TRIM60 inhibits MAPK/NF-κB activation and the innate immune response
    Zhiwen Gu
    Xueying Chen
    Wenyong Yang
    Yu Qi
    Hui Yu
    Xiaomeng Wang
    Yanqiu Gong
    Qianqian Chen
    Bo Zhong
    Lunzhi Dai
    Shiqian Qi
    Zhiqiang Zhang
    Huiyuan Zhang
    Hongbo Hu
    Cellular & Molecular Immunology, 2021, 18 : 1981 - 1994